Search

00

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Company

About Us
Advertising and Sponsorship
Profile & Readership
Contact Us
Latest News
Privacy & Cookies Policies
Terms of Use
Advertising Terms

Issue 81
Issue 80
Issue 79
Issue 78
Issue 77
Issue 76
Issue 75
Issue 74
Issue 73
Issue 72
Issue 71
Issue 70
View All

About the Awards
Awards Timetable
Awards Winners
Submit Nominations
Testimonials
Media Room
FAQ

Asset Management Awards
Brand of the Year Awards
Business Awards
Cash Management Banking Awards
Banking Technology Awards
CEO Awards
Customer Service Awards
CSR Awards
Deal of the Year Awards
Corporate Governance Awards
Corporate Banking Awards
Digital Transformation Awards
Fintech Awards
Education & Training Awards
ESG & Sustainability Awards
ESG Awards
Forex Banking Awards
Innovation Awards
Insurance & Takaful Awards
Investment Banking Awards

Investor Relations Awards
Leadership Awards
Islamic Banking Awards
Real Estate Awards
Project Finance Awards
Process & Product Awards
Telecommunication Awards
HR & Recruitment Awards
Trade Finance Awards
The Next 100 Global Awards
Wealth Management Awards
Travel Awards
Years of Excellence Awards
Publishing Principles
Ownership & Funding
Corrections Policy
Editorial Code of Ethics
Diversity & Inclusion Policy
Fact Checking Policy

Original content: Global Banking and Finance Review - https://www.globalbankingandfinance.com

A global financial intelligence and recognition platform delivering authoritative insights, data-driven analysis, and institutional benchmarking across Banking, Capital Markets, Investment, Technology, and Financial Infrastructure.

novel-therapies

Image for Investment Plan for Europe: EIB Backs Italian CNS Drug Developer Newron Pharmaceuticals with up to EUR 40m

novel-therapies

Investment Plan for Europe: Eib Backs Italian Cns Drug Developer Newron Pharmaceuticals With up to Eur 40m